News and Press Releases
ChinaBio Partnering Forum 2025: Connecting China’s Biotech Innovations with the Global Life Science Ecosystem
1 April 2025 -- Shanghai, China -- ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, returns in 2025 with a hybrid format to facilitate...
Category: Biotechnology, Other, Pharmaceutical
Posted: April 1, 2025
Kerry Hotel Pudong, Shanghai No. 1388, Hua mu Road, Pudong, Shanghai, 201204 China
Industry Leaders Address Future of Oncology Drugs and Biotech Funding at AAPS National Biotechnology Conference
Registration Now Open 26 March 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 National Biotechnology Conference (NBC), taking place...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2025
2107 Wilson Blvd #200 Arlington, VA 22201
ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May 25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 25, 2025
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
19 March 2025 -- Dublin, Ireland & New Jersey, US -- Amarin Corporation plc today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 24, 2025
MedExecWomen Hosts 6th Annual Conference to Discuss Future of Medtech Industry
18 March 2025 -- Massachusetts, US -- MedExecWomen, a non-profit organization focused on empowering executive women in medtech to accelerate the positive impact of medical devices, diagnostics, drug delivery, and...
Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: March 18, 2025
Fondazione Telethon Submits US Biological License Application for Etuvetidigene Autotemcel Gene Therapy for the Treatment of Wiskott-Aldrich Sydrome
11 March 2025 -- Milan, Italy -- Fondazione Telethon, an Italian biomedical charity focused on rare genetic diseases, announced that it has submitted the Biologics License Application (BLA) for the...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 11, 2025
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
10 March 2025 -- London, UK and New York, US -- OKYO Pharma Limited, a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 10, 2025
Cherwell supports microbiological environmental monitoring best practices conference
Cleanroom microbiology experts on hand at Pharmig’s specialist conference to discuss assessment of sterility in pharmaceutical manufacturing facilities 6 March 2025 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert,...
Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: March 6, 2025
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe
FDA, EMA grant BIOX-101 ODD status to treat intracerebral hemorrhagic stroke (ICH) ODD status may expedite drug candidate development and approvals BIOX-101 interim Phase 2a data in ICH imminent. 5...
Category: Drug Discovery, Other, Pharmaceutical
Posted: March 5, 2025
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
4 March 2025 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2025
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER-ILD, in progressive pulmonary fibrosis
Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 versus...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2025
ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025
24 January 2025 -- Cambridge, UK -- The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research...
Category: Drug Discovery, Other, Pharmaceutical
Posted: January 24, 2025
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
Opella reaches study milestone for Cialis
21 January 2025 -- Paris, France -- Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual...
Category: Clinical Trials, Other, Pharmaceutical
Posted: January 21, 2025
PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)
Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatment LYT-200...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 9, 2025
From Discovery Park to Merck, Top Industry Players to Showcase at London Biotechnology Show 2025
7 November 2024 -- London, UK -- Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 7, 2024
